ok- this was op’s call a while ago.
I believe, the most likely case moving forward with a treatment for CLBP is a $30m trial involving about 300 patients for 12 months duration . If investors don’t want to stick around that long...that’s their choice. I’m back( pun intended), but I will have something to say in the near future about management shortcomings...to say that they were fortunate to secure the backing of Surgecenter is a massive understatement..
Love your work OP
Reg
Ann: Mesoblast Update on Chronic Low Back Pain Program, page-44
-
- There are more pages in this discussion • 384 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.010(0.66%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.54 | $1.48 | $5.605M | 3.713M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 55197 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 29782 | 3 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |